Program Objectives At the conclusion of this activity, participants will be able to: ◾ ◾ Anticipate and correct problems related to P450 drug interactions ◾ ◾ Treat children and adolescents with bipolar mania ◾ ◾ Better understand the clinical relevance of the neuroprotective effects of lithium ◾ ◾ Be more discriminating about when to prescribe antidepressants ◾ ◾ Select optimal medications for psychiatric disorders in women of child-bearing potential ◾ ◾ Select optimal medications for patients with obsessive-compulsive disorder Massachusetts Psychiatric Society’s 28th Annual Psychopharmacology Update Program Overview The MPS is pleased to present our 28th Annual Psychopharmacology Update. This year’s conference will once again feature lectures focused on evidence-informed practice. David Osser will open the program with a review and workshop on Cytochrome P450 drug interactions, followed by a trio of talks on topics related to bipolar disorders by C. Iraklis Giakoumatos, Othman Mohammad, and Nassir Ghaemi. Dr. Mohammad’s presentation will be of special interest to child and adolescent psychiatrists. Following lunch, there will be a presentation on problems with how to interpret and apply the antidepressant literature in clinical practice, by Mark Zimmerman from Brown University. Dr. Zimmerman’s out-of-the-box thinking has challenged attendees to MPS Update meetings in the past, and we are very pleased he is able to be with us again this year. Next, a presentation on medications for women of child-bearing potential and in pregnancy by Fe Festin will take place. Lastly, the program will conclude with Harvard South Shore residents Ashley Beaulieu and Edward Tabasky discussing a new psycho- pharmacology algorithm for managing obsessive compulsive disorder, the latest from that department’s series of algorithm projects. Saturday October 21, 2017 7:45 a.m.–4:00 p.m. Massachusetts Medical Society 860 Winter Street, Waltham, MA 02451 To register for this event, visit www.psychiatry-mps.org, call (781) 237-8100, or fax (781) 464-4896. 7:45 a.m. Registration and Networking Breakfast 8:15 a.m. Welcome and Introduction David N. Osser, MD, Activity Chair Bushra Awidi, MD, Activity Co-chair C. Iraklis Giakoumatos, MD, Activity Co-chair 8:30 a.m. Review and Workshop on Cytochrome P450 Drug Interactions David N. Osser, MD 10:00 a.m. BREAK 10:30 a.m. Bipolar Disorders C. Iraklis Giakoumatos, MD — Neuroprotective Effects of Lithium Othman Mohammad, MD — Treatment of Bipolar Mania in Youths Nassir Ghaemi, MD — Update on Adult Psychopharmacology 12:15 p.m. LUNCH 1:00 p.m. Problems with the Antidepressant Literature: What’s a Clinician (and Insurance Company) to Do? Mark Zimmerman, MD 2:00 p.m. Medications for Women of Child- Bearing Potential and in Pregnancy Fe E. Festin, MD 3:00 p.m. Obsessive Compulsive Disorder: Psychopharmacology Algorithm Ashley Beaulieu, DO Edward Tabasky, MD 4:00 p.m. Adjourn Program Schedule AMA Credit Designation Statement The Massachusetts Psychiatric Society designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Accreditation Statement The Massachusetts Psychiatric Society is accredited by the Massachusetts Medical Society to provide continuing medical education for physicians.